- Home
- ALHC vs LGND Comparison
ALHC vs LGND Comparison
Compare ALHC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALHC | LGND |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALHC | LGND |
|---|---|---|
| Price | $20.51 | $231.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $23.13 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 3.3M | 181.1K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $3,948,719,000.00 | N/A |
| Revenue This Year | $33.69 | $1.25 |
| Revenue Next Year | $24.74 | $19.41 |
| P/E Ratio | $405.00 | ★ $76.27 |
| Revenue Growth | ★ 46.06 | N/A |
| 52 Week Low | $11.63 | $98.90 |
| 52 Week High | $23.87 | $247.38 |
Technical Indicators
Market Signals| Indicator | ALHC | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 56.39 |
| Support Level | $19.93 | $180.85 |
| Resistance Level | $20.71 | N/A |
| Average True Range (ATR) | 0.92 | 10.07 |
| MACD | -0.03 | -0.29 |
| Stochastic Oscillator | 53.85 | 34.46 |
Price Performance
Historical ComparisonAbout ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.